Fortress Biotech, Inc.FBIONASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank64
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Percentile
P64
Within normal range
vs 3Y Ago
-3.2x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024-0.58-146.5%
2023-0.24-491.8%
2022-0.04-122.0%
20210.18+119.0%
2020-0.96+28.8%
2019-1.34-209.7%
2018-0.43+66.5%
2017-1.30-81.3%
2016-0.72-9.5%
2015-0.65-